Over-the-counter inhalers for asthma
Pro Research Analysisby 
Searched over 200M research papers
Over-the-Counter Asthma Inhalers: Safety, Effectiveness, and Risks
OTC Inhalers for Mild, Intermittent Asthma
Over-the-counter (OTC) inhalers, such as epinephrine-based products like Primatene Mist, are available for the treatment of mild, intermittent asthma in individuals aged 12 and older. When used as directed, these inhalers can be safe and effective for occasional relief of asthma symptoms in this specific group of patients 128. However, current asthma management guidelines recommend that individuals with persistent asthma should be under a physician’s care and receive inhaled corticosteroid therapy, not just rely on OTC inhalers 18.
Risks of Overuse and Misuse of OTC Inhalers
A major concern with OTC inhalers is the risk of overuse and misuse, especially among people with moderate or persistent asthma. Studies show that a significant portion of OTC inhaler users have asthma that is not mild or intermittent, and these individuals are at higher risk for severe adverse effects, including increased emergency room visits, poor asthma control, and even death 1356+1 MORE. Overuse of short-acting beta-2 agonists (SABA) and epinephrine inhalers is linked to more frequent asthma attacks and exacerbations, as well as undertreatment of the underlying inflammation in asthma 3568.
Prevalence and Patterns of OTC Inhaler Use
The prevalence of OTC SABA inhaler use varies widely, with studies reporting that between 1.4% and 39.6% of asthma patients purchase these medications without a prescription 356. Many patients who use OTC inhalers do so without regular medical supervision, and some rely on these inhalers as their only asthma medication, which is not recommended by current guidelines 569. This pattern of use is associated with poor asthma outcomes and increased healthcare utilization 356.
Cost-Effectiveness and Alternatives to OTC Epinephrine Inhalers
Recent research suggests that if as-needed budesonide-formoterol (a combination inhaled corticosteroid and long-acting beta-agonist) were made available OTC, it would be more cost-effective and safer than OTC epinephrine inhalers for adults with mild asthma. Budesonide-formoterol use is associated with better asthma control, fewer severe exacerbations, and a lower risk of asthma-related death compared to epinephrine inhalers . This supports the idea that safer and more effective OTC options could improve outcomes for underinsured or underserved populations .
Concerns from Healthcare Professionals and Policy Implications
Many healthcare professionals and organizations express concern that making asthma medications available OTC could undermine asthma management guidelines, lead to increased costs, and worsen asthma control at the population level 78. There is also a disconnect between actual inhaler use and what is prescribed or recommended, making it difficult for clinicians to monitor and manage asthma effectively 569. Improved patient education, regular follow-up, and better communication between patients and healthcare providers are needed to ensure safe and effective use of inhalers 69.
Patient and Pharmacist Perspectives
Both patients and pharmacists recognize the immediate relief provided by SABA inhalers, but there are concerns about over-reliance and improper use. Barriers such as language, health literacy, and long waiting times for medical care can contribute to unsafe use of OTC inhalers. Pharmacists play a key role in educating patients and assessing inhaler use, but more support and public education are needed to address these challenges .
Conclusion
OTC inhalers can provide quick relief for mild, intermittent asthma when used correctly, but their availability poses significant risks of overuse, poor asthma control, and adverse outcomes, especially for those with more severe asthma. Safer alternatives and better patient education, along with regular medical supervision, are essential to improve asthma management and reduce the risks associated with OTC inhaler use.
Sources and full results
Most relevant research papers on this topic
Safety of over-the-counter inhalers for asthma: report of the council on scientific affairs.
Over-the-counter epinephrine inhalers are safe and effective for mild, intermittent asthma when used according to label instructions, but misuse can cause severe adverse reactions, including death.
Over-the-Counter Bronchodilators Use Among Asthmatic Patients in Al-Medina Al-Monawwara
Over-the-counter bronchodilator use among asthma patients in Al-Medina Al-Monawwara increases the risk of significant ER visits, potentially indicating less asthma control and more SABA overuse.
Cost-effectiveness of budesonide-formoterol versus inhaled epinephrine in United States adults with mild asthma.
OTC as-needed budesonide-formoterol for treating mild asthma in underinsured adults without HCP management improves asthma outcomes, prevents fatalities, and is cost-saving.
DOI